Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
Tallon D, Wiles N, Campbell J, Chew-Graham C, Dickens C, Macleod U, Peters TJ, Lewis G, Anderson IM, Gilbody S, Hollingworth W, Davies S, Kessler D. Tallon D, et al. Among authors: anderson im. Trials. 2016 Feb 3;17:66. doi: 10.1186/s13063-016-1199-2. Trials. 2016. PMID: 26842107 Free PMC article. Clinical Trial.
State-dependent changes in hippocampal grey matter in depression.
Arnone D, McKie S, Elliott R, Juhasz G, Thomas EJ, Downey D, Williams S, Deakin JF, Anderson IM. Arnone D, et al. Among authors: anderson im. Mol Psychiatry. 2013 Dec;18(12):1265-72. doi: 10.1038/mp.2012.150. Epub 2012 Nov 6. Mol Psychiatry. 2013. PMID: 23128153
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R; Members of the Consensus Meeting. Cleare A, et al. Among authors: anderson im. J Psychopharmacol. 2015 May;29(5):459-525. doi: 10.1177/0269881115581093. Epub 2015 May 12. J Psychopharmacol. 2015. PMID: 25969470
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).
Kessler DS, MacNeill SJ, Tallon D, Lewis G, Peters TJ, Hollingworth W, Round J, Burns A, Chew-Graham CA, Anderson IM, Shepherd T, Campbell J, Dickens CM, Carter M, Jenkinson C, Macleod U, Gibson H, Davies S, Wiles NJ. Kessler DS, et al. Among authors: anderson im. BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218. BMJ. 2018. PMID: 30381374 Free PMC article. Clinical Trial.
Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
Rifkin-Zybutz R, MacNeill S, Davies SJ, Dickens C, Campbell J, Anderson IM, Chew-Graham CA, Peters TJ, Lewis G, Wiles N, Kessler D. Rifkin-Zybutz R, et al. Among authors: anderson im. J Psychopharmacol. 2020 Dec;34(12):1342-1349. doi: 10.1177/0269881120965939. Epub 2020 Nov 4. J Psychopharmacol. 2020. PMID: 33143538 Free PMC article. Clinical Trial.
210 results